Barr Cipro Generic Takes 50% Share; Erosion Slow Under Bayer Deal
Executive Summary
Barr's generic ciprofloxacin has captured roughly half of Cipro prescriptions after five weeks on the market
You may also be interested in...
Bayer Focuses Internally: In-Licensing, In-House R&D Are Priorities
Bayer will focus on seeking licensing deals for its pharmaceutical business after abandoning a search for a more extensive partnership, CEO Werner Wenning told analysts Nov. 11
Bayer Focuses Internally: In-Licensing, In-House R&D Are Priorities
Bayer will focus on seeking licensing deals for its pharmaceutical business after abandoning a search for a more extensive partnership, CEO Werner Wenning told analysts Nov. 11
Bayer Baycol (correction)
Bayer has settled 1,211 Baycol lawsuits since the statin was withdrawn from the market, not 2,211 as reported by "The Pink Sheet" (1Aug. 11, 2003, p. 18). Bayer settled 400 lawsuits between its first and second quarter earnings conference calls...